Centiva Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Centiva Capital’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-90,000	Closed	-$3.68M	–	2754
2024 Q2	$3.68M	Buy	90,000 +71,000	+374%	+$2.96M	0.06%	215
2024 Q1	$803K	Buy	+19,000	New	+$798K	0.02%	768

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Centiva Capital's CERE Position: Q3 2024 in Review

Centiva Capital sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 90,000 shares — an estimated $3.68M sold.

Centiva Capital first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $3.68M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Centiva Capital reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Centiva Capital sold 90,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $3.68M.
Centiva Capital first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
Centiva Capital's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $3.68M in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.